Dr Siok Tey is a Group Leader at QIMR Berghofer Medical Research Institute and a Senior Staff Specialist in Haematology and Bone Marrow Transplantation at the Royal Brisbane and Women’s Hospital.  She received her medical training in the University of Queensland, and research training at the Center for Cell and Gene Therapy, Baylor College of Medicine (USA), followed by a PhD in immunology at QIMR Berghofer.  Her research interests are the immunobiology of bone marrow transplantation and the development of novel immunotherapeutics using cell and gene technology. She has led one of the first clinical trials using gene-modified T cells in Australia and is currently leading a phase I clinical trial using in-house generated Chimeric Antigen Receptor (CAR) T cells.